What is the main business of Fitome?

The main business activity of Fitome focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 12, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Marsz. Józefa Piłsudskiego 74, 50-020 Wrocław.

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $95,166, representing an increase of 1123.3% compared to 2023.

No, the company recorded a net loss of $43,947 in 2024. For comparison, in 2023 the loss was $17,937, meaning the company increased its loss by 132.7%.

What is the main operating cost?

The largest operating cost category falls under depreciation and amortization. This category amounted to $107,724 in 2024, representing 77% of all operating expenses.

Fitomesp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-06-12

Share capital

10,000.00 PLN

Registered address

ul. Marsz. Józefa Piłsudskiego 74/320, 50-020 Wrocław, Poland

Website

fitome.pl

Phone

Social media

Electronic delivery address

AE:PL-66960-26215-FTSHT-28

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2023, 361 days late).

2025not filed
202411/07/2025
202311/07/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 95.17kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD -43.95kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 139.11kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 16.97kMedianUSD 133.19kAverageUSD 3.03m

Industry

Offer

Dietary supplements
Herbal preparations
Adaptogenic preparations
Detox preparations
Respiratory preparations

Website technology

Online shop

WooCommerce

Website

WordPress
Elementor

Authorized Representatives

Anastasiya Piterska – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
ASI Platinum Alfa sp. z o.o. + limited partnership	50	$675.31	25%
Anastasiya Piterskaage 30	150	$2,025.93	75%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-06-16.

BNP Paribas Bank Polska
12 1600 1462 1739 2569 8000 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 14, 2023	Aid for SME access to finance — aid for start-ups	$84,720$84,720	Dyrektor Narodowego Centrum Badań i Rozwoju

Competitors

Name	Revenue	Website
Vasa Therapeuticssp. z o.o.	$363,111.30	vasatherapeutics.com
MultiqureS.A.	$284,781.52	purebiologics.com
Vitrotest Europesp. z o.o.	$233,350.77	vitrotest.pl
GMT Foodsafetysp. z o.o.	$207,064.75	gmtfoodsafety.com
Relvosp. z o.o.	$120,693.26	relvo.pl
Microblicsp. z o.o.	$122,383.50	microblic.pl
ModicaP.S.A.	$103,400.72	modica.bio
AI Corelabsp. z o.o.	$106,857.00	aicorelab.com
Microbe Plussp. z o.o.	$104,197.26	microbe-plus.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl